36 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• Avenue Therapeutics, Inc. ATXI climbed 193% to $0.9962 after jumping 36% on Monday.
• GBS Inc. GBS rose 73.3% to $0.7971 after declining around 9% on Monday.
• iQIYI, Inc. IQ shares gained 33.5% to $5.53 after the company reported fourth-quarter FY21 revenue of $1.2 billion, flat year-on-year, beating the consensus of $1.15 billion.
• Oak Street Health Inc OSH gained 29.3% to $$22.65. Oak Street reported FY21 revenue of $1.43 billion.
• UserTesting, Inc. USER shares gained 26.2% to $10.50 after the company reported better-than-expected Q4 EPS and sales results. The company also issued Q1 and FY22 EPS and sales guidance above analysts’ estimates.
• Veritiv Corporation VRTV gained 22.9% to $131.73 after the company posted upbeat quarterly results.
• Danimer Scientific Inc DNMR climbed 22.1% to $$4.86 following narrower-than-expected quarterly loss.
• LivePerson, Inc. LPSN gained 19.9% to $24.31. Starboard Value raised its stake in LivePerson from 8.5% to 9.7%.
• AVITA Medical, Inc. RCEL surged 19.5% to $11.00 following Q2 results.
• Quantum-Si Inc QSI climbed 18.8% to $4.94 following Q4 results.
• Avinger, Inc. AVGR rose 18.4% to $0.3078. Avinger recently reported successful completion of first cases with Lightbox 3 next generation imaging console.
• BP Prudhoe Bay Royalty Trust BPT gained 15.8% to $14.62 as the Russia-Ukraine conflict caused supply concerns.
• Humanigen, Inc. HGEN gained 15.3% to $2.34. Humanigen recently reported a FY21 net loss of $4.04 per share.
• American Rebel Holdings, Inc. AREB rose 15% to $1.53. American Rebel recently reported closing of $10.5 million public offering.
• Cano Health, Inc. CANO gained 14% to $5.55. Cano Health delayed Q4 earnings release and conference call.
• Guardforce AI Co., Limited GFAI shares rose 14% to $0.6724.
• Target Corporation TGT gained 11.6% to $223.03 after the company reported better-than-expected Q4 EPS results and issued FY22 guidance.
• Ucommune International Ltd UK shares rose 7.1% to $0.4349 after dipping around 17% on Monday.

Losers

• GoodRx Holdings, Inc. GDRX shares dipped 38% to $17.00 after the company reported worse-than-expected Q4 EPS and sales results and issued Q1 sales guidance below estimates.
• Vroom, Inc. VRM fell 39% to $3.7150 after the company reported worse-than-expected Q4 EPS results.
• Mullen Automotive, Inc. MULN fell 30.8% to $1.1699 after gaining over 145% on Monday. Mullen Automotive recently announced progress on solid-state polymer battery pack development.
• ZimVie Inc. ZIMV dipped 30% to $26.35. Credit Suisse initiated coverage on ZimVie with an Underperform rating and announced a price target of $34.
• Ambarella, Inc. AMBA fell 28.6% to $99.75 after the company reported Q4 earnings results and issued guidance.
• eHealth, Inc. EHTH dipped 28% to $11.17 after the company reported worse-than-expected Q4 sales results.
• Imperial Petroleum Inc. IMPP fell 26.6% to $1.74.
• Semler Scientific, Inc. SMLR dipped 22.3% to $56.74 after the company reported Q4 EPS and sales results down from last year.
• James River Group Holdings, Ltd. JRVR dropped 21.5% to $20.87 after the company reported Q4 EPS results down from last year.
• Heron Therapeutics, Inc. HRTX fell 21% to $5.61 after the company reported worse-than-expected Q4 sales results.
• Atara Biotherapeutics, Inc. ATRA dropped 19.8% to $10.30 after the company reported worse-than-expected Q4 EPS results.
• Endo International plc ENDP dropped 19.7% to $2.4950 after the company reported Q4 earnings results.
• Intellia Therapeutics, Inc. NTLA fell 18% to $80.99. Eight months after delivering promising biomarker data from one of the first CRISPR trials, Intellia Therapeutics presented additional data from the Phase 1 trial for NTLA-2001 in transthyretin, or ATTR, amyloidosis.
• Paya Holdings Inc. PAYA dipped 17.8% to $5.30 following Q4 results.
• CSP Inc. CSPI fell 17.3% to $6.82.
• ON24, Inc. ONTF dipped 17% to $12.95 after the company issued Q1 and FY22 guidance below analyst estimates.
• BigCommerce Holdings, Inc. BIGC dropped 17% to $21.47 after the company reported worse-than-expected Q4 adjusted EPS results and issued guidance.
• Zeta Global Holdings Corp. ZETA fell 14.9% to $11.07.